Relationship between hybrid capture II ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings

Asian Pacific Journal of Allergy and Immunology

Volumn 27, Issue 4, 2009, Pages 217-224

  Lurchachaiwong, Woradee ^a   Junyangdikul, Pairoj ^b   Payungporn, Sunchai ^a   Chansaenroj, Jira ^a   Sampatanukul, Pichet ^a   Tresukosol, Damrong ^a   Termrungruanglert, Wichai ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Samitivej Srinakharin Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; PROTEIN E6; PROTEIN L1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; MASS SCREENING; MOLECULAR HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS GENE; WART VIRUS; CYTOLOGY; GENETICS; METHODOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR;

CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 77953637088     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Moscicki AB, Shiboski S, Hills NK, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364:1678-83.
2. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998; 91:973-6.
3. Sherman ME, Schiffman MH, Lorincz AT. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 1997; 81:89-97.
4. Depuydt CE, Vereecken AJ, Salembier GM, et al. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003; 88:560-6.
5. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med 2003; 127: 940-5.
6. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996; 22:629-36.
7. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16:1-17.
8. Seme K, Fujs K, Kocjan BJ, Poljak M. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods 2006; 134:252-6.
9. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Ka-riya K. A Large case-control study of cervical cancer risk as-sociated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004; 189:1829-32.
10. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170:1077-85.
11. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37:2508-17.
12. Han J, Swan DC, Smith SJ, et al. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol 2006; 44:4157-62.
13. Jiang HL, Zhu HU, Zhou LF, Chen F, Chen Z. Genotyping of human papillomavirus in cervical lesion by L1 consensus PCR and the Luminex xMAP system. J Med Microbiol 2006; 55:715-20.
14. Federschneider JM, Yuan L, Brodsky J, Breslin G, Betensky RA, Crum CP. The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis. Am J Obstet Gynecol 2004; 191:757-61.
15. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al. Entire genome characterization of human papillomavirus type 16 (HPV16) from infected Thai women with different cytological findings. Virus Genes 2009; 39:30-8.
16. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wo-linsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7:209-14.
17. Evander M, Edlund K, BodÉn E, et al. Comparison of one-step and two step polymerase chain reaction with degenerate general primers in population-based study of Human papil-lomavirus infection in young Swedish women. J Clin Micro-biol 1992; 30:987-92.
18. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group specific dif-ferentation between high- and low-risk human papillomavi-rus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33:901-5.
19. Shadrina MI, Semenova EV, Slominsky PA. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage. BMC Med Genet 2007; 8:6.
20. Lurchachaiwong W, Payungporn S, Srisatidnarakul U, Mungkundar C, Theamboonlers A, Poovorawan Y. Rapid detection and strain identification of porcine reproductive and respiratory syndrome virus (PRRSV) by real-time RT-PCR. Lett Appl Microbiol 2008; 46:55-60.